Heffernan Michael Thomas 4
4 · Avalo Therapeutics, Inc. · Filed Mar 26, 2025
Insider Transaction Report
Form 4
Heffernan Michael Thomas
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-03-25+50,000→ 50,000 totalExercise: $8.54Exp: 2035-03-25→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The stock option vests in three substantially equal annual installments on the first, second and third anniversary of the date of grant, subject to the Eligible Director's continued service on each such vesting date.